Pharmosa Biopharm Company Description

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan.

It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease.

The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016.

Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.

Pharmosa Biopharm Inc.

Country	Taiwan
Founded	2000
Industry	Biotechnology
Sector	Healthcare
CEO	Pei Kan

Contact Details

Address: No. 508, Sec. 7, Zhongxiao E. Rd. Taipei City Taiwan
Phone	886 2 2782 7561
Website	pharmosa.com.tw

Stock Details

Ticker Symbol	6875
Exchange	Taipei Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006875008
SIC Code	2836

Key Executives

Name	Position
Dr. Pei Kan Ph.D.	President, GM and Director
Winny Yang	Vice President of Finance and Accounting
Hui-An Pao	Vice President of Operations
Ru-Yun Lin M.B.A.	Vice President of Administration